In this study, MK2206, an inhibitor of AKT, inhibited CCT8-induced cell migration and tumor metastasis, suggesting that CCT8 promotes cell migration and tumor metastasis by activating AKT (Fig. 4J). This evidence concerns the gene AKT1 and neoplasm.